Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ping An Biomedical CoPASW -6.49%17 EV-to-EBITDA is -8.38 as of Jul. 25, 2026. GuruFocus rates PASW with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 864 Manufacturing - Apparel & Accessories companies, Ping An Biomedical Co ranks worse than 115740.63% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ping An Biomedical Co's enterprise value is $16.82 Mil.
Ping An Biomedical Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $-2.01 Mil. Therefore, Ping An Biomedical Co's EV-to-EBITDA for today is -8.38.
The historical rank and industry rank for Ping An Biomedical Co's EV-to-EBITDA or its related term are showing as below:
PASW'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -9.71 Med: -2.12 Max: 1032.22
Current: -8.38
During the past 5 years, the highest EV-to-EBITDA of Ping An Biomedical Co was 1032.22. The lowest was -9.71. And the median was -2.12.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Ping An Biomedical Co (NAS:PASW) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ping An Biomedical Co's PE Ratio (TTM) for today is calculated as:
Ping An Biomedical Co's share price for today is $0.124.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ping An Biomedical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.087.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Ping An Biomedical Co EV-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Ping An Biomedical Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Textile Manufacturing subindustry, Ping An Biomedical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ping An Biomedical Co EV-to-EBITDA vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Ping An Biomedical Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ping An Biomedical Co's EV-to-EBITDA falls into.
Ping An Biomedical Co's current Enterprise Value is $16.82 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ping An Biomedical Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $-2.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ping An Biomedical Co (PASW) has a EV-to-EBITDA of -8.38 as of Jul. 25, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ping An Biomedical Co. According to the industry distribution chart, Ping An Biomedical Co ranks #999999 out of 864 companies in the Manufacturing - Apparel & Accessories industry.
Is Ping An Biomedical Co's EV-to-EBITDA too high?
Ping An Biomedical Co's current EV-to-EBITDA is -8.38. Based on the distribution chart, Ping An Biomedical Co ranks #999999 out of 864 companies in the Manufacturing - Apparel & Accessories industry, which is in the bottom quartile relative to peers. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's EV-to-EBITDA compare to DXYN and CULP?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Ping An Biomedical Co ranks #999999 out of 864 companies for EV-to-EBITDA. This places Ping An Biomedical Co in the lower half of its industry. The industry median EV-to-EBITDA is 9.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Manufacturing - Apparel & Accessories company?
The median EV-to-EBITDA among Manufacturing - Apparel & Accessories companies is 9.71, based on 864 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ping An Biomedical Co. For the Manufacturing - Apparel & Accessories industry, the median EV-to-EBITDA is 9.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ping An Biomedical Co's current EV-to-EBITDA is -8.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current EV-to-EBITDA of -8.38. The current EV-to-EBITDA is -8.38. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current EV-to-EBITDA is -8.38 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score
Get the complete analysis for PASW
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PASW has been successfully added to your 
